Roland B. Walter, MD, PhD
Dr. Walter is a hematologist who specializes in treating AML.Title
- Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
- Assistant Professor of Medicine, Division of Hematology, University of Washington School of Medicine
Clinical Specialties:
- Hematology
- Internal Medicine
Clinical Expertise
Acute Myelogenous Leukemia
Education And Training
- MD: University of Zürich, Zürich, Switzerland, 1990-1997
- PhD: University of Washington, Seattle, WA, 2004-2006
- Internship and Residency, Internal Medicine: Kantonsspital, Chur, and University Hospital, Zürich, Switzerland, 1997-2002
- Clinical Fellowship, Hematology: University of Washington, Seattle, WA, 2005-2007
- Research Fellowship: Fred Hutchinson Cancer Research Center, Seattle, WA, 2002-2007
More Information
For more information about Dr. Roland B. Walter's clinical and research expertise, click here.
Clinical Trials
Dr. Walter is the SCCA lead investigator for the following clinical trials:
- Early Discharge and Outpatient Care MDS and AML Patients
- Decitabine + Mitoxantrone Hydrochloride, Etoposide, and Cytarabine for AML or MDS (2652)
- CSL362 for CD123+ Acute Myeloid Leukemia Currently in Remission